Mikromir-Moleküle

European patent · EP2623599 · In force

Register entry

Publication number
EP2623599
Application number
EP12191739
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 3, 2008
Published
Aug 7, 2013
Granted
Jan 2, 2019
Protection ends at the latest
Oct 2, 2028
Next annual fee due
Oct 31, 2026
IPC classes
C12N 15/11 (2006.01)
A61K 31/712 (2006.01)
A61K 31/7088 (2006.01)
A61P 3/06 (2006.01)
A61K 31/7115 (2006.01)
A61P 31/14 (2006.01)
C12N 15/113 (2010.01)
Priority
US 977497 P 04.10.2007
US 979217 P 11.10.2007
US 28062 12.02.2008
EP 08104780 17.07.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Feb 21, 2025

    Holder’s address changed

    Owner
    Roche Innovation Center Copenhagen A/S, Fremtidsvej 3, 2970 Hørsholm, Denmark → RICC A/S, c/o Roche Diagnostics A/S, Flaskehalsen 17, 4., 1799 Kobenhavn V, Denmark

    Published in Swissreg on 21.02.2025

  3. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  4. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  5. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  6. Jan 7, 2019

    Granted

    Published in Swissreg on 07.01.2019

Parties

Holder

RICC A/S

c/o Roche Diagnostics A/S Flaskehalsen 17, 4., 1799 Kobenhavn V, DK

Inventor

Heidenblad, Markus

226 47 Lund, SE

Elmén, Joacim

120 67 Stockholm, SE

Obad, Susanna

217 57 Malmø, SE

Lindow, Morten

2450 Copenhagen SV, DK

Kauppinen, Sakari

2765 Smoerum, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.